Total Payments
$6,685
2024 Payments
$26.73
Companies
28
Transactions
427
Medicare Patients
3,236
Medicare Billing
$306,926
Payment Breakdown by Category
Food & Beverage$6,625 (99.1%)
Education$30.27 (0.5%)
Other$28.79 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,625 | 421 | 99.1% |
| Education | $30.27 | 5 | 0.5% |
| Entertainment | $28.79 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,561 | 74 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $905.33 | 58 | $0 (2021) |
| GlaxoSmithKline, LLC. | $870.19 | 72 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $566.74 | 54 | $0 (2019) |
| Genentech USA, Inc. | $488.26 | 28 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $287.42 | 13 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $275.21 | 26 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $245.05 | 15 | $0 (2020) |
| Mallinckrodt Enterprises LLC | $205.83 | 10 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $186.77 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.73 | 2 | GlaxoSmithKline, LLC. ($26.73) |
| 2023 | $30.85 | 1 | Inspire Medical Systems, Inc. ($30.85) |
| 2021 | $17.27 | 2 | AstraZeneca Pharmaceuticals LP ($14.77) |
| 2020 | $539.19 | 33 | AstraZeneca Pharmaceuticals LP ($129.18) |
| 2019 | $1,749 | 98 | AstraZeneca Pharmaceuticals LP ($279.79) |
| 2018 | $2,495 | 158 | Boehringer Ingelheim Pharmaceuticals, Inc. ($643.60) |
| 2017 | $1,826 | 133 | Boehringer Ingelheim Pharmaceuticals, Inc. ($571.64) |
All Payment Transactions
427 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: RESPIRATORY | ||||||
| 01/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: NEUROLOGY | ||||||
| 06/30/2021 | United Therapeutics Corporation | ORENITRAM (Drug) | Education | In-kind items and services | $2.50 | General |
| Category: PAH | ||||||
| 05/14/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Respiratory | ||||||
| 06/10/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.61 | General |
| 03/12/2020 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: RESPIRATORY | ||||||
| 03/11/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: RESPIRATORY | ||||||
| 03/10/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Respiratory | ||||||
| 03/10/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: RESPIRATORY | ||||||
| 03/09/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/06/2020 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Respiratory and Allergy | ||||||
| 03/04/2020 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: Cardiology | ||||||
| 03/03/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Respiratory | ||||||
| 03/02/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug), OFEV | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: RESPIRATORY | ||||||
| 02/28/2020 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Pulmonology | ||||||
| 02/26/2020 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: RESPIRATORY | ||||||
| 02/21/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: Respiratory | ||||||
| 02/21/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $0.18 | General |
| Category: Respiratory | ||||||
| 02/19/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Respiratory | ||||||
| 02/18/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/17/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: RESPIRATORY | ||||||
| 02/12/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Respiratory | ||||||
| 02/11/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: RESPIRATORY | ||||||
| 02/06/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 456 | 463 | $198,773 | $43,951 |
| 2022 | 8 | 667 | 718 | $296,173 | $69,134 |
| 2021 | 10 | 901 | 985 | $367,008 | $98,495 |
| 2020 | 15 | 1,212 | 1,388 | $355,564 | $95,346 |
Total Patients
3,236
Total Services
3,554
Medicare Billing
$306,926
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 187 | 190 | $53,327 | $17,581 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 67 | 67 | $26,854 | $7,685 | 28.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 55 | $21,910 | $7,462 | 34.1% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 46 | 46 | $32,168 | $4,050 | 12.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 41 | 42 | $29,593 | $3,826 | 12.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $5,485 | $1,809 | 33.0% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 40 | 40 | $25,800 | $1,151 | 4.5% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 12 | 12 | $3,636 | $386.43 | 10.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 239 | 278 | $70,890 | $23,679 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 104 | 104 | $40,560 | $11,465 | 28.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 70 | 70 | $34,300 | $11,102 | 32.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 74 | 83 | $28,552 | $10,362 | 36.3% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 52 | 55 | $39,270 | $4,925 | 12.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 56 | 56 | $39,648 | $4,368 | 11.0% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 61 | 61 | $39,345 | $1,889 | 4.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $3,608 | $1,344 | 37.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 260 | 311 | $79,440 | $30,292 | 38.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 122 | 144 | $49,536 | $20,664 | 41.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 132 | 132 | $51,576 | $16,620 | 32.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 67 | 67 | $32,876 | $10,478 | 31.9% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2021 | 89 | 90 | $63,720 | $8,211 | 12.9% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Facility | 2021 | 55 | 62 | $44,268 | $5,908 | 13.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 34 | 35 | $3,990 | $2,080 | 52.1% |
| 94375 | Respiratory diagnostic testing (flow volume loop) | Office | 2021 | 75 | 76 | $8,892 | $1,682 | 18.9% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2021 | 43 | 43 | $27,735 | $1,621 | 5.8% |
About Dr. Christopher Pugh, MD
Dr. Christopher Pugh, MD is a Sleep Medicine healthcare provider based in Stuart, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972535698.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Pugh, MD has received a total of $6,685 in payments from pharmaceutical and medical device companies, with $26.73 received in 2024. These payments were reported across 427 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($6,625).
As a Medicare-enrolled provider, Pugh has provided services to 3,236 Medicare beneficiaries, totaling 3,554 services with total Medicare billing of $306,926. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Stuart, FL
- Active Since 07/06/2006
- Last Updated 10/11/2023
- Taxonomy Code 207RS0012X
- Entity Type Individual
- NPI Number 1972535698
Products in Payments
- OFEV (Drug) $629.39
- FASENRA (Drug) $449.31
- NUCALA (Biological) $374.32
- SYMBICORT (Drug) $364.80
- STIOLTO RESPIMAT (Drug) $363.56
- Xolair (Biological) $316.06
- STIOLTO (Drug) $311.41
- XOLAIR (Biological) $245.05
- DUPIXENT (Biological) $243.32
- Utibron (Drug) $206.96
- ACTHAR (Biological) $205.83
- Esbriet (Biological) $172.20
- DUPIXENT (Drug) $167.73
- LONHALA MAGNAIR (Drug) $167.49
- BREO (Drug) $166.77
- TRELEGY ELLIPTA (Drug) $160.44
- CINQAIR (Drug) $159.47
- UTIBRON (Drug) $153.61
- ANORO (Drug) $139.88
- QVAR (Drug) $105.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.